U.S. RESEARCH ROUNDUP- Adobe, Aligos Therapeutics

TCR2 Therapeutics

23/03/2022 07:23

March 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Adobe, Aligos Therapeutics and Terns Pharmaceuticals
on Wednesday. 
    
    HIGHLIGHTS      
       * Adobe Inc  ADBE.O : Jefferies raises target price to $570 from $550
       * Aligos Therapeutics Inc  ALGS.O : Piper Sandler cuts to neutral from overweight
       * Terns Pharmaceuticals Inc  TERN.O : JP Morgan cuts to neutral from overweight 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.     

     * 2Seventy Bio Inc  TSVT.O : Wedbush cuts target price to $27 from $34
     * AAR Corp  AIR.N : RBC raises target price to $56 from $50
     * Absci Corp  ABSI.O : Credit Suisse cuts target price to $28 from $29
     * Adobe Inc  ADBE.O : Credit Suisse cuts target price to $525 from $625
     * Adobe Inc  ADBE.O : Jefferies raises target price to $570 from $550
     * Adobe Inc  ADBE.O : Piper Sandler cuts target price to $545 from $600
     * Aligos Therapeutics Inc  ALGS.O : Jefferies cuts target price to $2.50 from $5
     * Aligos Therapeutics Inc  ALGS.O : Piper Sandler cuts price target to $4 from $15
     * Aligos Therapeutics Inc  ALGS.O : Piper Sandler cuts to neutral from overweight
     * Booking Holdings Inc  BKNG.O : Jefferies raises target price to $2,900 from $2,800
     * Camden Property Trust  CPT.N : RBC raises target price to $182 from $180
     * Dariohealth Corp  DRIO.O : Craig-Hallum cuts target price to $18 from $22
     * Decibel Therapeutics Inc  DBTX.O : Jonestrading cuts target price to $16 from $25
     * Enanta Pharmaceuticals Inc  ENTA.O : JP Morgan cuts target price to $74 from $89
     * Exagen Inc  XGN.O : Canaccord Genuity cuts target price to $20 from $22
     * Finance of America Companies Inc  FOA.N : Credit Suisse cuts target price to $7 from $9
     * Freightcar America Inc  RAIL.O : Stephens raises target price to $5 from $4
     * GDS Holdings  GDS.O : Cowen and Company cuts target price to $53 from $99
     * Hain Celestial Group Inc  HAIN.O : Jefferies cuts price target to $38 from $41
     * Harpoon Therapeutics Inc  HARP.O : Canaccord Genuity cuts target price to $14 from $30
     * Krystal Biotech Inc  KRYS.O : H.C. Wainwright cuts target price to $107 from $124
     * Mosaic Co  MOS.N : CIBC raises target price to $67 from $48
     * Nextera Energy Partners LP  NEP.N : RBC raises target price to $86 from $80
     * Ondas Holdings Inc  ONDS.O : Oppenheimer cuts target price to $11 from $12
     * Science 37 Holdings Inc  SNCE.O : Cowen and Company cuts target price to $10 from $18
     * Snap One Holdings Corp  SNPO.O : Jefferies cuts target price to $25 from $30
     * Snap One Holdings Corp  SNPO.O : JP Morgan cuts target price to $24 from $25
     * TCR2 Therapeutics Inc  TCRR.O : Jefferies cuts price target to $19 from $24
     * TCR2 Therapeutics Inc  TCRR.O : Piper Sandler cuts target price to $23 from $26
     * TCR2 Therapeutics Inc  TCRR.O : SVB Leerink cuts target price to $3 from $7
     * Terns Pharmaceuticals Inc  TERN.O : JP Morgan cuts to neutral from overweight 
     * Terns Pharmaceuticals Inc  TERN.O : JP Morgan cuts target price to $6 from $19
     * Tyson Foods Inc  TSN.N : Piper Sandler cuts target price to $87 from $90
     * Vertex Pharmaceuticals Inc  VRTX.O : Piper Sandler raises target price to $245 from $241
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))